THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14


  • Thieves’ Market showcases tricky clinical cases

    Thieves’ Market showcases tricky clinical cases

    The annual ‘Thieves’ Market: Show Me Your Best Cases’ features a series of mysterious clinical cases pertaining to rheumatology. Physicians this year shared their stories of patients experiencing symptoms ranging from loose teeth to pale hands to an increased stroke risk. READ MORE

  • Experts debate wisdom of tapering bDMARDs in patients with LDA

    Experts debate wisdom of tapering bDMARDs in patients with LDA

    This year’s Great Debate focused on the value of tapering biologic DMARDs (bDMARDs) in patients with rheumatoid arthritis who have achieved low disease activity (LDA). READ MORE

  • IL-1 antagonists may have role in cancer fight

    IL-1 antagonists may have role in cancer fight

    Anakinra, an interleukin antagonist commonly used in the treatment of rheumatoid arthritis, is also used for other inflammatory diseases and recently has been studied as a treatment with chemotherapy for some cancers, according to Charles Dinarello, MD, who presented the Rheumatology Research Foundation Philip Hench, MD Memorial Lecture on Monday. READ MORE

  • Gluck lecture examines crisis in osteoporosis care

    Gluck lecture examines crisis in osteoporosis care

    “A big part of the crisis has to do with how we use bisphosphonates safely and effectively,” said Kenneth G. Saag, MD, MSc, the Jane Knight Lowe Professor and Vice Chair of Medicine and Director of the Center for Outcomes, Effectiveness Research, and Education at the University of Alabama at Birmingham. READ MORE

  • It’s a 3-peat for The Hawkeyes

    It’s a 3-peat for The Hawkeyes

    Make it three Knowledge Bowl championships in three years for The Hawkeyes from the University of Iowa. READ MORE

  • NIH plan helps investigators get an early career boost

    NIH plan helps investigators get an early career boost

    “We have a specific commitment to the next generation of clinician scientists,” said Stephen I. Katz, MD, PhD, Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of NIH. READ MORE

  • MACRA looks here to stay, so clinics need to be ready

    MACRA looks here to stay, so clinics need to be ready

    Alex Limanni, MD, Rheumatologist at the Arthritis Centers of Texas in Dallas, explained the outcome measures that determine a MIPS score, which is based on a 100-point scale. READ MORE

  • Journey to Erdheim-Chester diagnosis described in detail

    Journey to Erdheim-Chester diagnosis described in detail

    At this year’s Clinicopathologic Conference, a team of four physicians from the National Institutes of Health and George Washington University presented a case study of a rare inflammatory disease and the series of imaging and pathology tests they conducted to finally arrive at a diagnosis. READ MORE

  • Curbside Consults offers glimpse into trio of rare diseases

    A popular feature of the Annual Meeting, the Curbside Consults: Ask the Professors session this year featured three professors addressing some rare and difficult-to-diagnose diseases they have treated. READ MORE

  • Rheumatology Research Foundation honors award recipients

    Rheumatology Research Foundation honors award recipients

    Rheumatology Research Foundation President Eric Matteson, MD, MPH, recognized 175 award recipients on Monday at the Foundation’s Annual Awards Luncheon. READ MORE